3/20
12:21 pm
drio
DarioHealth (DRIO) had its price target lowered by Stifel Nicolaus from $16.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
DarioHealth (DRIO) had its price target lowered by Stifel Nicolaus from $16.00 to $10.00. They now have a "buy" rating on the stock.
3/19
03:27 pm
drio
DarioHealth Corp (DRIO) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges [Yahoo! Finance]
Medium
Report
DarioHealth Corp (DRIO) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges [Yahoo! Finance]
3/19
01:33 pm
drio
DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
DarioHealth Corp. (DRIO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/19
10:02 am
drio
DarioHealth Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
DarioHealth Q4 Earnings Call Highlights [Yahoo! Finance]
3/19
06:46 am
drio
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results [Yahoo! Finance]
Low
Report
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results [Yahoo! Finance]
3/19
06:30 am
drio
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Low
Report
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
3/11
08:30 am
drio
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
Low
Report
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
3/10
08:23 am
drio
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health [Yahoo! Finance]
Medium
Report
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health [Yahoo! Finance]
3/10
08:00 am
drio
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
Medium
Report
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
3/3
08:00 am
drio
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
Medium
Report
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
1/25
03:05 am
drio
Low
Report
1/21
08:00 am
drio
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
Medium
Report
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
1/9
02:37 am
drio
How The DarioHealth (DRIO) Story Is Shifting With A Higher Target And Ongoing Risks [Yahoo! Finance]
Medium
Report
How The DarioHealth (DRIO) Story Is Shifting With A Higher Target And Ongoing Risks [Yahoo! Finance]
1/3
01:06 am
drio
High
Report
12/21
01:08 am
drio
DarioHealth (NASDAQ:DRIO) was upgraded by analysts at
Wall Street Zen
High
Report